Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;75(6):530-534.
doi: 10.1097/FJC.0000000000000826.

Direct Oral Anticoagulants for the Treatment of Left Ventricular Thrombus-A New Indication? A Meta-summary of Case Reports

Daniela Tomasoni  1 , Edoardo Sciatti, Andrea Bonelli, Enrico Vizzardi, Marco Metra
Affiliations
Review

Direct Oral Anticoagulants for the Treatment of Left Ventricular Thrombus-A New Indication? A Meta-summary of Case Reports

Daniela Tomasoni et al. J Cardiovasc Pharmacol. 2020 Jun.

Abstract

Left ventricular thrombus (LVT) can be a consequence of cardiac diseases such as heart failure with reduced ejection fraction and acute myocardial infarction. Currently, the guidelines recommend the use of warfarin for the treatment of this condition. However, there are increasing reports of patients with LVTs being treated with direct oral anticoagulants (DOACs), for several reasons. We set out to review the available literature to assess the safety and the efficacy of this approach. We analyzed 52 cases, extrapolated by 34 papers contained in literature, focusing on the characteristics of patients, treatment, outcome, and follow-up. Rivaroxaban was the most commonly used DOAC, followed by apixaban. The diagnosis of LVT and the follow-up were mainly performed by transthoracic echocardiography. The thrombus resolved in 45 patients (92%) of 49 (there are no data available regarding the outcome of 3 patients) and failed to resolve in 4 patients treated with DOACs. The resolution occurred in a median of 32 days. DOACs are shown to be a reasonable and valid option for the treatment of LVT. Our study provides a rationale for a prospective randomized controlled trial.

PubMed Disclaimer

References

    1. Vaitkus PT, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol. 1993;22:1004–1009.
    1. Asinger RW, Mikell FL, Elsperger J, et al. Incidence of left ventricular thrombosis after acute transmural myocardial infarction: series evaluation by two dimensional echocardiography. N Engl J Med. 1981;305:297–302.
    1. Visser CA, Kan G, Meltzer RS, et al. Embolic potential of left ventricular thrombus after myocardial infarction: a two-dimensional echocardiographic study of 119 patients. J Am Coll Cardiol. 1985;5:1276–1280.
    1. Delewi R, Zijlistra F, Pick JJ. Left ventricular thrombus formation after acute myocardial infarction. Heart. 2012;98:1743–1749.
    1. Solheim S, Seljeflot I, Lunde K, et al. Frequency of left ventricular thrombus in patients with percutaneous coronary intervention and dual antiplatelet therapy. Am J Cardiol. 2010;106:1197–1200.

Substances

LinkOut - more resources